207 related articles for article (PubMed ID: 22298838)
1. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Doria-Rose VP; Laiyemo AO; Church T; Yokochi LA; Yurgalevitch S; Rathmell J; Andriole GL; Buys S; Crawford ED; Fouad M; Isaacs C; Lamerato L; Reding D; Prorok PC; Berg CD;
J Natl Cancer Inst; 2012 Feb; 104(4):280-9. PubMed ID: 22298838
[TBL] [Abstract][Full Text] [Related]
2. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial.
Laiyemo AO; Doubeni C; Pinsky PF; Doria-Rose VP; Bresalier R; Hickey T; Riley T; Church TR; Weissfeld J; Schoen RE; Marcus PM; Prorok PC
J Gen Intern Med; 2015 Oct; 30(10):1447-53. PubMed ID: 25835747
[TBL] [Abstract][Full Text] [Related]
4. Results of repeat sigmoidoscopy 3 years after a negative examination.
Schoen RE; Pinsky PF; Weissfeld JL; Bresalier RS; Church T; Prorok P; Gohagan JK;
JAMA; 2003 Jul; 290(1):41-8. PubMed ID: 12837710
[TBL] [Abstract][Full Text] [Related]
5. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities.
Laiyemo AO; Doubeni C; Pinsky PF; Doria-Rose VP; Bresalier R; Lamerato LE; Crawford ED; Kvale P; Fouad M; Hickey T; Riley T; Weissfeld J; Schoen RE; Marcus PM; Prorok PC; Berg CD
J Natl Cancer Inst; 2010 Apr; 102(8):538-46. PubMed ID: 20357245
[TBL] [Abstract][Full Text] [Related]
6. Yield of advanced adenoma and cancer based on polyp size detected at screening flexible sigmoidoscopy.
Schoen RE; Weissfeld JL; Pinsky PF; Riley T
Gastroenterology; 2006 Dec; 131(6):1683-9. PubMed ID: 17188959
[TBL] [Abstract][Full Text] [Related]
7. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
Gohagan JK; Prorok PC; Hayes RB; Kramer BS;
Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Schoen RE; Pinsky PF; Weissfeld JL; Yokochi LA; Church T; Laiyemo AO; Bresalier R; Hickey T; Riley T; Prorok PC
Gastrointest Endosc; 2012 Mar; 75(3):612-20. PubMed ID: 22341106
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Hocking WG; Hu P; Oken MM; Winslow SD; Kvale PA; Prorok PC; Ragard LR; Commins J; Lynch DA; Andriole GL; Buys SS; Fouad MN; Fuhrman CR; Isaacs C; Yokochi LA; Riley TL; Pinsky PF; Gohagan JK; Berg CD;
J Natl Cancer Inst; 2010 May; 102(10):722-31. PubMed ID: 20442215
[TBL] [Abstract][Full Text] [Related]
10. Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis.
Jeon J; Meza R; Hazelton WD; Renehan AG; Luebeck EG
Cancer Causes Control; 2015 Jun; 26(6):859-70. PubMed ID: 25783458
[TBL] [Abstract][Full Text] [Related]
11. Variability in flexible sigmoidoscopy performance among examiners in a screening trial.
Pinsky PF; Schoen RE; Weissfeld JL; Kramer B; Hayes RB; Yokochi L;
Clin Gastroenterol Hepatol; 2005 Aug; 3(8):792-7. PubMed ID: 16234008
[TBL] [Abstract][Full Text] [Related]
12. Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Weissfeld JL; Ling BS; Schoen RE; Bresalier RS; Riley T; Prorok PC;
Cancer; 2002 May; 94(10):2569-76. PubMed ID: 12173322
[TBL] [Abstract][Full Text] [Related]
13. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Prorok PC; Andriole GL; Bresalier RS; Buys SS; Chia D; Crawford ED; Fogel R; Gelmann EP; Gilbert F; Hasson MA; Hayes RB; Johnson CC; Mandel JS; Oberman A; O'Brien B; Oken MM; Rafla S; Reding D; Rutt W; Weissfeld JL; Yokochi L; Gohagan JK;
Control Clin Trials; 2000 Dec; 21(6 Suppl):273S-309S. PubMed ID: 11189684
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy.
Laiyemo AO; Doubeni C; Pinsky PF; Doria-Rose VP; Sanderson AK; Bresalier R; Weissfeld J; Schoen RE; Marcus PM; Prorok PC; Berg CD
Cancer Epidemiol; 2012 Aug; 36(4):395-9. PubMed ID: 22112544
[TBL] [Abstract][Full Text] [Related]
15. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Kitahara CM; Berndt SI; de González AB; Coleman HG; Schoen RE; Hayes RB; Huang WY
J Clin Oncol; 2013 Jul; 31(19):2450-9. PubMed ID: 23715565
[TBL] [Abstract][Full Text] [Related]
16. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
Andriole GL; Crawford ED; Grubb RL; Buys SS; Chia D; Church TR; Fouad MN; Isaacs C; Kvale PA; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hsing AW; Izmirlian G; Pinsky PF; Kramer BS; Miller AB; Gohagan JK; Prorok PC;
J Natl Cancer Inst; 2012 Jan; 104(2):125-32. PubMed ID: 22228146
[TBL] [Abstract][Full Text] [Related]
18. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Weissfeld JL; Fagerstrom RM; O'Brien B;
Control Clin Trials; 2000 Dec; 21(6 Suppl):390S-399S. PubMed ID: 11189690
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).
Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB
Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805
[TBL] [Abstract][Full Text] [Related]
20. Cumulative incidence of false-positive results in repeated, multimodal cancer screening.
Croswell JM; Kramer BS; Kreimer AR; Prorok PC; Xu JL; Baker SG; Fagerstrom R; Riley TL; Clapp JD; Berg CD; Gohagan JK; Andriole GL; Chia D; Church TR; Crawford ED; Fouad MN; Gelmann EP; Lamerato L; Reding DJ; Schoen RE
Ann Fam Med; 2009; 7(3):212-22. PubMed ID: 19433838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
